Cargando…

The microcirculatory characteristics of the heart and lung meridians: Study protocol clinical trial (SPIRIT Compliant)

INTRODUCTION: The aim of the present study is to compare the microcirculatory difference of different meridians by using laser doppler flowmetry and investigate the specificity for the meridian-visceral association and site-to-site association between 2 specific meridians. METHODS AND ANALYSIS: The...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Hantong, Jiang, Yongliang, Li, Xiaoyu, Lou, Jiali, Zhang, Yajun, He, Xiaofen, Fang, Junfan, Wu, Yuanyuan, Shao, Xiaomei, Fang, Jianqiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220657/
https://www.ncbi.nlm.nih.gov/pubmed/32243379
http://dx.doi.org/10.1097/MD.0000000000019594
_version_ 1783533211870035968
author Hu, Hantong
Jiang, Yongliang
Li, Xiaoyu
Lou, Jiali
Zhang, Yajun
He, Xiaofen
Fang, Junfan
Wu, Yuanyuan
Shao, Xiaomei
Fang, Jianqiao
author_facet Hu, Hantong
Jiang, Yongliang
Li, Xiaoyu
Lou, Jiali
Zhang, Yajun
He, Xiaofen
Fang, Junfan
Wu, Yuanyuan
Shao, Xiaomei
Fang, Jianqiao
author_sort Hu, Hantong
collection PubMed
description INTRODUCTION: The aim of the present study is to compare the microcirculatory difference of different meridians by using laser doppler flowmetry and investigate the specificity for the meridian-visceral association and site-to-site association between 2 specific meridians. METHODS AND ANALYSIS: The Lung and Heart meridians are chosen as 2 specific studied meridians. 120 participants will be enrolled and divided into the healthy control group, chronic stable angina pectoris group and healthy intervention group. Laser doppler flowmetry will be used to assess the blood perfusion of the Heart and Lung meridians. The specificity for the meridian-visceral association will be investigated by comparing the microcirculatory difference between the Heart and Lung meridians in the healthy control group and chronic stable angina pectoris group. Besides, participants in the healthy intervention group will receive 2 sessions of moxibustion in the Heart meridian and Lung meridian, respectively, to explore the specificity for the site-to-site association on the body surface. Primary outcomes will be blood flow curve and blood perfusion units of relevant sites along the Heart and Lung meridians. Statistical analysis will be conducted by third party statisticians. ETHICS AND DISSEMINATION: Ethics approval (approval No: ZSLL-KY-2019-001A-01) has been obtained from the Ethics Committee of the Third Affiliated Hospital of Zhejiang Chinese Medical University. The study findings will be disseminated through presentation at peer-reviewed medical journals. TRIAL REGISTRATION: ClinicalTrials.gov NCT04244812.
format Online
Article
Text
id pubmed-7220657
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-72206572020-06-15 The microcirculatory characteristics of the heart and lung meridians: Study protocol clinical trial (SPIRIT Compliant) Hu, Hantong Jiang, Yongliang Li, Xiaoyu Lou, Jiali Zhang, Yajun He, Xiaofen Fang, Junfan Wu, Yuanyuan Shao, Xiaomei Fang, Jianqiao Medicine (Baltimore) 3800 INTRODUCTION: The aim of the present study is to compare the microcirculatory difference of different meridians by using laser doppler flowmetry and investigate the specificity for the meridian-visceral association and site-to-site association between 2 specific meridians. METHODS AND ANALYSIS: The Lung and Heart meridians are chosen as 2 specific studied meridians. 120 participants will be enrolled and divided into the healthy control group, chronic stable angina pectoris group and healthy intervention group. Laser doppler flowmetry will be used to assess the blood perfusion of the Heart and Lung meridians. The specificity for the meridian-visceral association will be investigated by comparing the microcirculatory difference between the Heart and Lung meridians in the healthy control group and chronic stable angina pectoris group. Besides, participants in the healthy intervention group will receive 2 sessions of moxibustion in the Heart meridian and Lung meridian, respectively, to explore the specificity for the site-to-site association on the body surface. Primary outcomes will be blood flow curve and blood perfusion units of relevant sites along the Heart and Lung meridians. Statistical analysis will be conducted by third party statisticians. ETHICS AND DISSEMINATION: Ethics approval (approval No: ZSLL-KY-2019-001A-01) has been obtained from the Ethics Committee of the Third Affiliated Hospital of Zhejiang Chinese Medical University. The study findings will be disseminated through presentation at peer-reviewed medical journals. TRIAL REGISTRATION: ClinicalTrials.gov NCT04244812. Wolters Kluwer Health 2020-04-03 /pmc/articles/PMC7220657/ /pubmed/32243379 http://dx.doi.org/10.1097/MD.0000000000019594 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 3800
Hu, Hantong
Jiang, Yongliang
Li, Xiaoyu
Lou, Jiali
Zhang, Yajun
He, Xiaofen
Fang, Junfan
Wu, Yuanyuan
Shao, Xiaomei
Fang, Jianqiao
The microcirculatory characteristics of the heart and lung meridians: Study protocol clinical trial (SPIRIT Compliant)
title The microcirculatory characteristics of the heart and lung meridians: Study protocol clinical trial (SPIRIT Compliant)
title_full The microcirculatory characteristics of the heart and lung meridians: Study protocol clinical trial (SPIRIT Compliant)
title_fullStr The microcirculatory characteristics of the heart and lung meridians: Study protocol clinical trial (SPIRIT Compliant)
title_full_unstemmed The microcirculatory characteristics of the heart and lung meridians: Study protocol clinical trial (SPIRIT Compliant)
title_short The microcirculatory characteristics of the heart and lung meridians: Study protocol clinical trial (SPIRIT Compliant)
title_sort microcirculatory characteristics of the heart and lung meridians: study protocol clinical trial (spirit compliant)
topic 3800
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220657/
https://www.ncbi.nlm.nih.gov/pubmed/32243379
http://dx.doi.org/10.1097/MD.0000000000019594
work_keys_str_mv AT huhantong themicrocirculatorycharacteristicsoftheheartandlungmeridiansstudyprotocolclinicaltrialspiritcompliant
AT jiangyongliang themicrocirculatorycharacteristicsoftheheartandlungmeridiansstudyprotocolclinicaltrialspiritcompliant
AT lixiaoyu themicrocirculatorycharacteristicsoftheheartandlungmeridiansstudyprotocolclinicaltrialspiritcompliant
AT loujiali themicrocirculatorycharacteristicsoftheheartandlungmeridiansstudyprotocolclinicaltrialspiritcompliant
AT zhangyajun themicrocirculatorycharacteristicsoftheheartandlungmeridiansstudyprotocolclinicaltrialspiritcompliant
AT hexiaofen themicrocirculatorycharacteristicsoftheheartandlungmeridiansstudyprotocolclinicaltrialspiritcompliant
AT fangjunfan themicrocirculatorycharacteristicsoftheheartandlungmeridiansstudyprotocolclinicaltrialspiritcompliant
AT wuyuanyuan themicrocirculatorycharacteristicsoftheheartandlungmeridiansstudyprotocolclinicaltrialspiritcompliant
AT shaoxiaomei themicrocirculatorycharacteristicsoftheheartandlungmeridiansstudyprotocolclinicaltrialspiritcompliant
AT fangjianqiao themicrocirculatorycharacteristicsoftheheartandlungmeridiansstudyprotocolclinicaltrialspiritcompliant
AT huhantong microcirculatorycharacteristicsoftheheartandlungmeridiansstudyprotocolclinicaltrialspiritcompliant
AT jiangyongliang microcirculatorycharacteristicsoftheheartandlungmeridiansstudyprotocolclinicaltrialspiritcompliant
AT lixiaoyu microcirculatorycharacteristicsoftheheartandlungmeridiansstudyprotocolclinicaltrialspiritcompliant
AT loujiali microcirculatorycharacteristicsoftheheartandlungmeridiansstudyprotocolclinicaltrialspiritcompliant
AT zhangyajun microcirculatorycharacteristicsoftheheartandlungmeridiansstudyprotocolclinicaltrialspiritcompliant
AT hexiaofen microcirculatorycharacteristicsoftheheartandlungmeridiansstudyprotocolclinicaltrialspiritcompliant
AT fangjunfan microcirculatorycharacteristicsoftheheartandlungmeridiansstudyprotocolclinicaltrialspiritcompliant
AT wuyuanyuan microcirculatorycharacteristicsoftheheartandlungmeridiansstudyprotocolclinicaltrialspiritcompliant
AT shaoxiaomei microcirculatorycharacteristicsoftheheartandlungmeridiansstudyprotocolclinicaltrialspiritcompliant
AT fangjianqiao microcirculatorycharacteristicsoftheheartandlungmeridiansstudyprotocolclinicaltrialspiritcompliant